LINDON, UT--(Marketwire - Oct 25, 2011) - ZYTO Corp (
ZYTO Corp, a Utah-based company specializing in biocommunication applications, today announced the appointment of leading experts to its newly formed Scientific Advisory Board. Vaughn R Cook, OMD, ZYTO's CEO said, "We are very fortunate to have these key leaders as members of our team. Their background and experience are very valuable to ZYTO as we continue to enhance our products and develop more research programs."
The members of ZYTO's Scientific Advisory Board include: Daniel Clark, M.D., Lee Cowden, M.D., Dennis Cozzocrea, D.C., William Gonseaux, Jane Oelke, N.D., Ph.D., Tobin Watkinson, D.C.
For a complete biography on each member, please visit http://www.zyto.com/advisoryboard.html.
On September 8, 2011, ZYTO announced the approval of its 510(k) filing with the United States Food and Drug Administration (FDA) for the ZYTO Hand Cradle.
"Having FDA registration on the Hand Cradle opens more doors for research and further advancement of ZYTO technology," said Kami J. Howard, ZYTO's President, "and our Scientific Advisory Board becomes more important to us as we pursue those opportunities."
The Scientific Advisory Board will meet periodically throughout the year. The next meeting will be held on November 5th.
About ZYTO Corp
ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options.
For more information visit www.ZYTO.com or contact their Headquarters at 801-224-7199.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.
Contact Information:
ZYTO Corp
801-224-7199